| Product Code: ETC7651090 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Industry Life Cycle |
3.4 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Porter's Five Forces |
3.5 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of exocrine pancreatic insufficiency (EPI) in Israel |
4.2.2 Growing investments in research and development for EPI therapeutics and diagnostics |
4.2.3 Rising prevalence of EPI due to lifestyle changes and increasing geriatric population in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of EPI therapeutics and diagnostics in Israel |
4.3.2 Limited reimbursement options for EPI treatments in the country |
5 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Trends |
6 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Types |
6.1 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.1.4 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Pancreatic Function Test, 2021- 2031F |
6.2 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Nutritional Management, 2021- 2031F |
6.2.3 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Pancreatic Enzyme Replacement Therapy, 2021- 2031F |
6.3 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Generic, 2021- 2031F |
6.3.3 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Branded, 2021- 2031F |
6.4 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.6 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Research and Academic Institute, 2021- 2031F |
6.4.7 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Import-Export Trade Statistics |
7.1 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Export to Major Countries |
7.2 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Imports from Major Countries |
8 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for EPI therapeutics and diagnostics in Israel |
8.2 Adoption rate of new EPI diagnostic technologies in healthcare facilities |
8.3 Number of healthcare providers specializing in EPI management in Israel |
9 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Opportunity Assessment |
9.1 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Competitive Landscape |
10.1 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Israel Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here